(株)Veritas In Silicoの貸借残高情報
主市場 | 業種 | 証券コード/EDINET | 英名称 |
---|
東証GRT | 医薬品 | 130A/ - | - |
公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
---|
2024/08/02 | 日証協 | 706,285株 | -7.3% | 245,492株 | +12.51% | 458,876株 | -8.13% | 37,100株 | -5.62% |
2024/07/26 | 日証協 | 761,885株 | +14.21% | 218,192株 | +34.69% | 499,466株 | +10.56% | 39,310株 | -14% |
2024/07/19 | 日証協 | 667,085株 | -6.49% | 161,992株 | +146.2% | 451,766株 | -6.07% | 45,710株 | +111.52% |
2024/07/12 | 日証協 | 713,385株 | -1.27% | 65,796株 | -70.56% | 480,946株 | -0.76% | 21,610株 | -79.52% |
2024/07/05 | 日証協 | 722,585株 | +21.53% | 223,485株 | +295.55% | 484,646株 | +25.54% | 105,500株 | +258.84% |
2024/06/28 | 日証協 | 594,596株 | +1.28% | 56,500株 | +404.46% | 386,046株 | -2.35% | 29,400株 | +250% |
2024/06/21 | 日証協 | 587,096株 | -0.94% | 11,200株 | -72.21% | 395,346株 | -2.25% | 8,400株 | +21.74% |
2024/06/14 | 日証協 | 592,696株 | -1.71% | 40,296株 | -53.47% | 404,446株 | -2.86% | 6,900株 | -2.82% |
2024/06/07 | 日証協 | 602,996株 | -9.97% | 86,596株 | +236.95% | 416,346株 | -8% | 7,100株 | +18.33% |
2024/05/31 | 日証協 | 669,796株 | -0.74% | 25,700株 | -77.09% | 452,546株 | -1.76% | 6,000株 | -76.19% |
2024/05/24 | 日証協 | 674,796株 | +2.29% | 112,196株 | -20.65% | 460,646株 | +3.48% | 25,200株 | -19.3% |
2024/05/17 | 日証協 | 659,696株 | -0.39% | 141,396株 | -9.48% | 445,149株 | +0.43% | 31,226株 | -56.75% |
2024/05/10 | 日証協 | 662,296株 | -4.96% | 156,196株 | +30.49% | 443,223株 | -6.44% | 72,200株 | +238.97% |
2024/05/02 | 日証協 | 696,896株 | -2.82% | 119,696株 | +102.55% | 473,725株 | -1.21% | 21,300株 | +9.79% |
2024/04/26 | 日証協 | 717,096株 | -0.6% | 59,096株 | -27.75% | 479,525株 | -0.56% | 19,401株 | -27.34% |
2024/04/19 | 日証協 | 721,396株 | -1.03% | 81,796株 | -51.6% | 482,222株 | -0.62% | 26,700株 | -49.91% |
2024/04/12 | 日証協 | 728,885株 | +2.4% | 168,992株 | -16.46% | 485,225株 | +0.87% | 53,300株 | -42.58% |
2024/04/05 | 日証協 | 711,785株 | +12.8% | 202,296株 | +32.32% | 481,025株 | +19.44% | 92,819株 | +0.31% |
2024/03/29 | 日証協 | 630,996株 | +6.8% | 152,885株 | +84.65% | 402,725株 | -0.89% | 92,528株 | +165.1% |
※株式分割は考慮していませんのでご注意ください。
Page Top